132 related articles for article (PubMed ID: 9117558)
21. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
Hof PR; Cox K; Morrison JH
J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
[TBL] [Abstract][Full Text] [Related]
22. Effects of wild-type and mutant human amyloid precursor protein on cortical afferent network.
Alpár A; Ueberham U; Seeger G; Arendt T; Gärtner U
Neuroreport; 2007 Aug; 18(12):1247-50. PubMed ID: 17632276
[TBL] [Abstract][Full Text] [Related]
23. Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways.
Hof PR; Vogt BA; Bouras C; Morrison JH
Vision Res; 1997 Dec; 37(24):3609-25. PubMed ID: 9425534
[TBL] [Abstract][Full Text] [Related]
24. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.
Bailey TL; Rivara CB; Rocher AB; Hof PR
Neurol Res; 2004 Jul; 26(5):573-8. PubMed ID: 15265277
[TBL] [Abstract][Full Text] [Related]
25. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
26. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
27. Evolution of Alzheimer's disease related cortical lesions.
Braak H; Braak E; Bohl J; Bratzke H
J Neural Transm Suppl; 1998; 54():97-106. PubMed ID: 9850918
[TBL] [Abstract][Full Text] [Related]
28. Early olfactory involvement in Alzheimer's disease.
Christen-Zaech S; Kraftsik R; Pillevuit O; Kiraly M; Martins R; Khalili K; Miklossy J
Can J Neurol Sci; 2003 Feb; 30(1):20-5. PubMed ID: 12619779
[TBL] [Abstract][Full Text] [Related]
29. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia.
Leuchter AF; Newton TF; Cook IA; Walter DO; Rosenberg-Thompson S; Lachenbruch PA
Brain; 1992 Oct; 115 ( Pt 5)():1543-61. PubMed ID: 1422803
[TBL] [Abstract][Full Text] [Related]
30. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
[TBL] [Abstract][Full Text] [Related]
31. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
Arnold SE; Hyman BT; Flory J; Damasio AR; Van Hoesen GW
Cereb Cortex; 1991; 1(1):103-16. PubMed ID: 1822725
[TBL] [Abstract][Full Text] [Related]
32. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
Dessi F; Colle MA; Hauw JJ; Duyckaerts C
Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
[TBL] [Abstract][Full Text] [Related]
33. Structural plasticity of synapses in Alzheimer's disease.
Adams IM
Mol Neurobiol; 1991; 5(2-4):411-9. PubMed ID: 1823143
[TBL] [Abstract][Full Text] [Related]
34. Networks of tau distribution in Alzheimer's disease.
Hoenig MC; Bischof GN; Seemiller J; Hammes J; Kukolja J; Onur ÖA; Jessen F; Fliessbach K; Neumaier B; Fink GR; van Eimeren T; Drzezga A
Brain; 2018 Feb; 141(2):568-581. PubMed ID: 29315361
[TBL] [Abstract][Full Text] [Related]
35. Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology.
Cullen KM; Halliday GM
Neurobiol Aging; 1998; 19(4):297-306. PubMed ID: 9733161
[TBL] [Abstract][Full Text] [Related]
36. Life and death of neurons in the aging cerebral cortex.
Morrison JH; Hof PR
Int Rev Neurobiol; 2007; 81():41-57. PubMed ID: 17433917
[TBL] [Abstract][Full Text] [Related]
37. [Relation between hippocampal damage and cerebral cortical function in Alzheimer's disease].
Hanyu H; Asano T; Kogure D; Sakurai H; Iwamoto T; Takasaki M
Nihon Ronen Igakkai Zasshi; 2000 Nov; 37(11):921-7. PubMed ID: 11193370
[TBL] [Abstract][Full Text] [Related]
38. Hypothalamic pathology in Alzheimer's disease.
Saper CB; German DC
Neurosci Lett; 1987 Mar; 74(3):364-70. PubMed ID: 2436113
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease in a patient with posterior cortical atrophy.
Berthier ML; Leiguarda R; Starkstein SE; Sevlever G; Taratuto AL
J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1110-1. PubMed ID: 1783928
[TBL] [Abstract][Full Text] [Related]
40. Neurochemical phenotype of corticocortical connections in the macaque monkey: quantitative analysis of a subset of neurofilament protein-immunoreactive projection neurons in frontal, parietal, temporal, and cingulate cortices.
Hof PR; Nimchinsky EA; Morrison JH
J Comp Neurol; 1995 Nov; 362(1):109-33. PubMed ID: 8576425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]